Investing.com - Merck Kgaa reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck Kgaa announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.51 on revenue of €5.42B.
Merck Kgaa shares are down 23.75% from the beginning of the year , still down 24.41% from its 52 week high of €231.30 set on Thursday, December 30, 2021. They are under-performing the EUR/USD which is down 0% year to date.
Merck Kgaa follows other major Healthcare sector earnings this month
Merck Kgaa's report follows an earnings beat by Merck on Friday, who reported EPS of €2.64 on revenue of €5.57B, compared to forecasts EPS of €2.51 on revenue of €5.42B.
Carl Zeiss AG had matched expectations on Friday with fourth quarter EPS of €0.7 on revenue of €477.4M, compared to forecast for EPS of €0.7 on revenue of €477.42M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar